|
IFT80 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.152010E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.122300E-03 |
| Normal-vs-Stage2 |
1.794740E-04 |
| Normal-vs-Stage3 |
1.50080000005381E-06 |
| Normal-vs-Stage4 |
2.042000E-03 |
| Stage1-vs-Stage2 |
8.843800E-02 |
| Stage1-vs-Stage3 |
1.632410E-02 |
| Stage1-vs-Stage4 |
5.218600E-01 |
| Stage2-vs-Stage3 |
9.794200E-01 |
| Stage2-vs-Stage4 |
3.832000E-01 |
| Stage3-vs-Stage4 |
2.644200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.414000E-04 |
| Normal-vs-AfricanAmerican |
5.976000E-02 |
| Normal-vs-Asian |
1.639900E-02 |
| Caucasian-vs-AfricanAmerican |
6.186400E-01 |
| Caucasian-vs-Asian |
5.237400E-01 |
| AfricanAmerican-vs-Asian |
9.829400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.39899999999738E-05 |
| Normal-vs-Female |
4.381500E-04 |
| Male-vs-Female |
2.252800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.184900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.187840E-04 |
| Normal-vs-Age(61-80Yrs) |
4.45010000005297E-06 |
| Normal-vs-Age(81-100Yrs) |
3.999700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.714000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.650260E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.798600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.961800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.066200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.362200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.127590E-01 |
| Classical-VS-Follicular |
4.268500E-02 |
| Classical-VS-Other |
7.686000E-01 |
| Classical-VS-Normal |
2.137900E-03 |
| Tall-VS-Follicular |
9.590200E-01 |
| Tall-VS-Other |
5.894600E-01 |
| Tall-VS-Normal |
4.020000E-04 |
| Follicular-VS-Other |
6.878000E-01 |
| Follicular-VS-Normal |
1.827720E-04 |
| Other-VS-Normal |
1.268230E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.76200000000715E-05 |
| Normal-vs-N1 |
3.968000E-02 |
| N0-vs-N1 |
1.194970E-01 |
|
|
